201

Vaccine

Hepatitis A (monovalent)

Circumstances

Vaccine may be provided to a child:

 (a) who is an Aboriginal or a Torres Strait Islander; and

 (b) who is at least 1 year old but less than 5 years of age; and

 (c) who lives in Queensland, Western Australia, South Australia or the Northern Territory

VAQTA Paediatric/ Adolescent

Injection (0.5mL)

Hepatitis A virus protein — 25 units of the hepatitis A virus protein

2 doses, with the second dose given 6 months after the first dose

202

Vaccine

Hepatitis B (monovalent adult)

Circumstances

Vaccine may be provided to a child who is at least 10 years old but less than 14 years of age.

H‑B‑Vax II

Vial for injection (1mL)

Hepatitis B surface antigen protein — 10 µg

2 doses, with the second dose given 4 to 6 months after the first dose

203

Vaccine

Hepatitis B (monovalent paediatric)

Circumstances

Vaccine may be provided in the circumstances set out in subsection 7 (4)

Engerix‑B

Vial for injection (0.5mL)

Hepatitis B surface antigen protein — 10 µg

1 dose or 3 doses

204

Vaccine

Hepatitis B (monovalent paediatric)

Circumstances

Vaccine may be provided to a newborn infant as soon as practicable after birth but no later than 7 days after birth.

H‑B‑Vax II

Vial for injection (0.5mL)

Hepatitis B surface antigen protein — 5 µg

1 dose

205

Vaccine

Influenza

Circumstances

Vaccine may be provided in the circumstances set out in subsection 7 (5)

Vaxigrip or Influvac or Fluarix

Injection (0.5mL)

For children older than 6 months but less than 9 years, 2 doses at least 1month apart for the first vaccination and 1 dose per calendar year after that. For persons 9 years and above, 1 dose per calendar year.

Note – For children aged between 6 months and less than 3 years the dose is 0.25ml

206

Vaccine

Influenza

Circumstances

Vaccine may be provided in the circumstances set out in subsection 7 (6)

Fluvax

Injection (0.5mL)

For children older than 5 years but less than 9 years, 2 doses at least 1 month apart for the first vaccination and 1 dose per calendar year after that. For persons 9 years and above, 1 dose per calendar year.

207

Vaccine

Influenza

Circumstances

Vaccine may be provided in the circumstances set out in subsection 7 (5)

Vaxigrip Junior

Injection (0.25mL)

For children older than 6 months but less than 3 years, 2 doses at least 1 month apart for the first vaccination and 1 dose per calendar year after that.

208

Vaccine

Measles, mumps and rubella

Circumstances

Vaccine may be provided to a child who is about 12 months old or 4 years of age.

M‑M‑R II

Refrigerated lyophilised preparation for injection (0.5mL)

Each of the following live attenuated viruses:

 (a) measles virus (Edmonston strain) — 1000 TCID50;

 (b) mumps virus (Jeryl Lynn strain) — 5000 TCID50;

 (c) rubella virus (Wistar RA 27/3 strain) — 1000 TCID50

2 doses

209

Vaccine

Measles, mumps and rubella

Circumstances

Vaccine may be provided to a child who is about 12 months old or 4 years of age.

Priorix

Refrigerated lyophilised preparation for injection (0.5mL)

Each of the following live attenuated viruses:

 (a) measles virus (Schwarz strain) — 103.0 CCID50;

 (b) mumps virus (RIT 4385 derived from the Jeryl Lynn strain) — 103.7 CCID50;

 (c) rubella virus (Wistar RA 27/3 strain) — 103.0 CCID50

2 doses

210

Vaccine

Measles, mumps, rubella and varicella

Circumstances

The Vaccine may be provided to a child who is about 18 months of age

Priorix-Tetra

Powder for injection vial with diluent syringe (0.5mL)

Each of the following live attenuated viruses:

(a)    measles virus (Schwarz strain) – 103.0 CCID50

(b)    mumps virus (RIT 4385 strain,derived from Jeryl Lynn strain) - 104.4CCID50

(c)    rubella virus (Wistar RA 27/3 strain) – 103.0 CCID50

(d)   varicella virus (Oka strain) - 103.3 PFU

1 dose

211

Vaccine

Poliomyelitis

Circumstances

Vaccine may be provided to a child who is about 2, 4 or 6 months old or 4 years of age, if all other vaccines containing poliovirus are unsuitable

IPOL

Injection (0.5mL)

Each of the following killed whole polioviruses:

 (a) type 1 (Mahoney) — 40 D‑antigen units;

 (b) type 2 (MEF‑1) — 8 D‑antigen units;

 (c) type 3 (Saukett) — 32 D‑antigen units

No more than 4 doses

212

Vaccine

Varicella

Circumstances

Vaccine may be provided to:

 (a) a child who is about 18 months old; or

 (b) a child who is at least 10 years old but less than 14 years of age, if the child:

 (i) has not had varicella; and

 (ii) has not been vaccinated against varicella.

Varilrix

Refrigerated lyophilised preparation for injection (0.5mL)

Live attenuated Oka strain of the varicella‑zoster virus — 103.3 PFU

1 dose

213

Vaccine

Varicella

Circumstances

Vaccine may be provided to:

 (a) a child who is about 18 months old; or

 (b) a child who is at least 10 years old but less than 14 years of age, if the child:

 (i) has not had varicella; and

 (ii) has not been vaccinated against varicella.

Varivax Refrigerated

Refrigerated lyophilised preparation for injection (0.5mL)

Live attenuated Oka/Merck strain of the varicella‑zoster virus — at least 1350 PFU

1 dose

214

Vaccine

Human papillomavirus (HPV)

Circumstances

Vaccine may be provided to:

 (a) a person who is at least 12 years old but less than 14 years of age; or

 (b) A male who, between 1 February 2013 and 31 December 2015, is at least 13 years old but less than 16 years old.

Gardasil

Injection (0.5mL)

Each of the following:

 (a) HPV 6 L1 protein — 20 µg;

 (b) HPV 11 L1 protein — 40 µg;

 (c) HPV 16 L1 protein — 40 µg;

 (d) HPV 18 L1 protein — 20 µg

3 doses

215

Vaccine

Human papillomavirus (HPV)

Circumstances

Vaccine may be provided to:

a female who is at least 12 years old but less than 14 years of age.

Cervarix

Injection (0.5mL)

Each of the following:

(a)   HPV 16 L1 protein - 20μg; 

(b)   HPV 18 L1 protein - 20μg 

3 doses

216

Vaccine

Rotavirus

Circumstances

Vaccine may be provided to a child who:

 (a) is about 2 or 4 months old.

Rotarix

Oral suspension (1.5mL) in oral applicator

Human rotavirus vaccine, live attenuated, RIX 4414 strain (G1P[8]) — not less than 106 CCID50

2 doses:

 (a) first dose given at 6 to 14 weeks of age;

 (b) second dose given at 14 to 24 weeks of age

217

Vaccine

Rotavirus

Circumstances

Vaccine may be provided to a child who:

 (a) is about 2, 4 or 6 months old.

RotaTeq

Oral solution (2.0mL)

Live pentavalent reassortant vaccine containing each of the following:

 (a) G1 — 2.2 x 106 IU;

 (b) G2 — 2.8 x 106 IU;

 (c) G3 — 2.2 x 106 IU;

 (d) G4 — 2.0 x 106 IU;

 (e) P1 (8) — 2.3 x 106 IU

3 doses:

 (a) first dose given at 6 to 14 weeks old;

 (b) second dose given at 14 to 24 weeks old;

   (c) third dose given before 32 weeks old